RFS Pharma
RFS Pharma is a pharmaceutical-sector entity that maintains a web domain at rfspharma.com. The source data provides no substantive information on its products, pipeline, technology, customers, or business model, limiting any functional description to the industry implied by its name.
- Company typePrivate
- Founded2004
- HeadquartersTucker, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What RFS Pharma does
RFS Pharma operates a web domain at rfspharma.com. The name suggests positioning within the pharmaceutical industry, but the source data provides no substantive description of the company's products, therapeutic focus, technology platform, pipeline, or commercial operations. The available webpage content consists solely of a third-party tracking pixel and a "Do Not Sell or Share My Personal Information" opt-out link, with no product information, company history, leadership disclosures, or business-model details. As a result, the company's functional description, core offerings, underlying technology, customer segments, and revenue mechanics cannot be determined from the provided material. This analysis is constrained entirely by the absence of public-facing substantive content; any specific claims about RFS Pharma's activities would require data not present in the input.
RFS Pharma firmographics
Firmographics- Name
- RFS Pharma
- Website
- https://rfspharma.com
- Company type
- Private
- Founded year
- 2004
- Headcount range
- 11–50 employees
- Short description
- RFS Pharma is a pharmaceutical-sector entity that maintains a web domain at rfspharma.com. The source data provides no substantive information on its products, pipeline, technology, customers, or business model, limiting any functional description to the industry implied by its name.
- Ownership category
- akta.pro rank
RFS Pharma industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)
- akta.pro secondary industries
- Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ), Small-Molecule API Process Development & Route Scouting (HLAGAHAA)
Keywords
Where RFS Pharma is headquartered
LocationHeadquarters
- HQ city
- Tucker
- HQ country
- United States
- HQ region
- North America
Markets served
RFS Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
RFS Pharma product offering
Product offeringCore offering
No substantive information about RFS Pharma's core offerings is available in the source data. The webpage at rfspharma.com contains only a tracking pixel placeholder and a privacy opt-out link, with no description of products, services, or business activities. The "Pharma" suffix in the company name is the only signal suggesting operation in the pharmaceutical sector.
Product overview
Based on the available source data, no specific product or service information is provided. The webpage content consists primarily of a tracking pixel placeholder and a privacy opt-out link, with no substantive information about RFS Pharma's product portfolio, offerings, or business focus.
Differentiator
Problem solved
Functional benefit
RFS Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
RFS Pharma partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
RFS Pharma competitors and assessment
Company assessmentDirect peers
- Lannett Company: Lannett is a US-based small-molecule generic pharmaceutical manufacturer focused on developing and distributing generic prescription medications. Its scale and domestic generic-pharma focus make it a directly comparable peer to RFS Pharma.
- Upsher-Smith Laboratories: Upsher-Smith is a privately-held US-based pharmaceutical company focused on generic and specialty small-molecule products. Its privately-held, domestic, small-pharma profile is directly comparable to RFS Pharma's apparent positioning.
- Amneal Pharmaceuticals: Amneal Pharmaceuticals is a US-based generic and specialty pharmaceutical company developing, manufacturing, and distributing small-molecule generics. It represents a relevant peer in the US small-molecule generics space that RFS Pharma operates in.
- Heritage Pharmaceuticals: Heritage Pharmaceuticals is a US-based generic pharmaceutical company offering a broad portfolio of generic medications. Its US-domestic, generic-focused, mid-scale operating model is closely comparable to what RFS Pharma's footprint suggests.
- ANI Pharmaceuticals: ANI Pharmaceuticals is a US-based specialty generic pharmaceutical company that develops, manufactures, and markets branded and generic prescription pharmaceuticals. As a similarly-sized, US-domiciled small-molecule pharma entity, it is a structurally comparable peer to RFS Pharma.
Broad incumbents
- Endo International: Endo International is a US-based specialty pharmaceutical and generics company with a focus on both branded and generic small-molecule products. As a broader incumbent in the US small-molecule space, it provides a comparable market reference point.
- Sandoz: Sandoz is the generics division of Novartis and a leading global generic pharmaceuticals manufacturer with substantial US presence. As a major incumbent in the US small-molecule generics category, it is a relevant peer for understanding market structure.
- Mallinckrodt plc: Mallinckrodt is a US-domiciled specialty pharmaceutical and generics manufacturer with a broad product portfolio. As a larger incumbent operating in overlapping therapeutic and generic categories, it serves as a relevant market-structure benchmark for RFS Pharma.
- Viatris: Viatris is a major global pharmaceutical company formed from the merger of Mylan and Upjohn, with a significant small-molecule generics portfolio in the US market. It serves as a broad incumbent peer defining the US generics competitive context.
- Teva Pharmaceutical Industries: Teva is one of the world's largest generic pharmaceutical manufacturers with extensive US operations across small-molecule generics. While far larger than RFS Pharma, Teva defines the competitive landscape and pricing dynamics of the US generics market in which RFS Pharma would participate.
Market position
Strengths1 record
Competitive moat2 records
Key highlights2 records
Customer concentration
RFS Pharma social profiles
Digital presenceRFS Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
RFS Pharma leadership team
Management profileNumber of profiles
RFS Pharma funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RFS Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RFS Pharma
What does RFS Pharma do?
No substantive information about RFS Pharma's core offerings is available in the source data. The webpage at rfspharma.com contains only a tracking pixel placeholder and a privacy opt-out link, with no description of products, services, or business activities. The "Pharma" suffix in the company name is the only signal suggesting operation in the pharmaceutical sector.
When was RFS Pharma founded?
RFS Pharma was founded in 2004. It employs 11 to 50 people.
Where is RFS Pharma based?
RFS Pharma is headquartered in Tucker, United States, in the North America region.
Who are RFS Pharma's main competitors?
Direct peers on record are Lannett Company, Upsher-Smith Laboratories, Amneal Pharmaceuticals, Heritage Pharmaceuticals and ANI Pharmaceuticals. Broad incumbents are Endo International, Sandoz, Mallinckrodt plc, Viatris and Teva Pharmaceutical Industries.
Does RFS Pharma have an API?
No public API is recorded for RFS Pharma.
What industry is RFS Pharma in?
RFS Pharma's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIABAA, Small-Molecule Generics (Branded/Unbranded), with a secondary code of HLAIABAJ, Generic ANDA/Regulatory Affairs & Submissions. Its NAICS code is 325412 and its SIC code is 2834.